Monday, July 15, 2024

Impact of Polycystic Ovary Syndrome on Birth Outcomes: A Comprehensive Study

Similar articles

Emerging evidence highlights the need for healthcare systems to address the potential risks associated with polycystic ovary syndrome (PCOS) in pregnant women. A recent systematic review and meta-analysis, encompassing 73 studies and 92,881 offspring, delves into the association between PCOS and adverse birth outcomes. The study underscores the importance of recognizing PCOS status during pregnancy to mitigate risks and improve neonatal health.

PCOS and Birth Outcomes

Women diagnosed with PCOS tend to be younger, have a higher body mass index (BMI) around the time of conception, and experience greater gestational weight gain compared to their non-PCOS counterparts. This condition has been linked to increased odds of preterm birth, fetal growth restrictions, and low birth weight. Notably, the analysis suggests that many of these adverse outcomes, including lower mean birthweight and a higher incidence of small-for-gestational-age infants, may occur independently of BMI.

Research Findings and Implications

The findings from this comprehensive study informed the recent 2023 international guidelines for the assessment and management of PCOS. These guidelines advocate for the systematic capture of PCOS status during pregnancy as a means to identify and mitigate risks, thereby enhancing birth outcomes. This approach is aligned with broader healthcare strategies aimed at improving market access to quality prenatal care for women with PCOS, ensuring that interventions are appropriately targeted.

Market access considerations are crucial in this context, as they determine the availability and affordability of healthcare resources necessary to manage PCOS during pregnancy. By understanding the specific needs of this population, healthcare providers can tailor their services to better support women with PCOS, ultimately reducing the likelihood of adverse birth outcomes.

Key Inferences

Based on the study’s findings, several valuable inferences can be drawn:

  • PCOS is associated with a higher risk of adverse birth outcomes, necessitating closer monitoring and management during pregnancy.
  • Interventions should be designed to address the unique challenges faced by women with PCOS, including higher BMI and gestational weight gain.
  • Systematic identification of PCOS status in pregnant women can lead to better-targeted healthcare interventions, improving neonatal health.
  • Ensuring market access to specialized prenatal care for women with PCOS is vital for mitigating risks and promoting healthy birth outcomes.

The study’s comprehensive analysis and its implications underscore the importance of tailored healthcare strategies to address the needs of pregnant women with PCOS. By enhancing market access to specialized care, the healthcare system can better support this population, ultimately leading to improved birth outcomes and healthier offspring.

Original Article:

Nat Commun. 2024 Jul 4;15(1):5592. doi: 10.1038/s41467-024-49752-6.

ABSTRACT

You can follow our news on our Telegram and LinkedIn accounts.

It is unclear whether polycystic ovary syndrome (PCOS) is an independent risk factor for adverse birth outcomes in the offspring of affected women. Here, we investigate the association of PCOS with birth outcomes in the offspring of women with PCOS overall and by potential confounders. This systematic review and meta-analysis included 73 studies and 92,881 offspring of women with and without PCOS from inception until 13th July 2022. We report that mothers with PCOS are younger and have higher body mass index (BMI) around conception and have greater gestational weight gain. The odds of preterm birth, fetal growth restriction and low birth weight are higher and mean birthweight is lower in PCOS of which a lower mean birthweight and a higher small for gestational age are probably independent of BMI. This work informed the recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome, emphasizing that PCOS status should be captured at pregnancy to identify risk and improve birth outcomes in the offspring.

PMID:38965241 | DOI:10.1038/s41467-024-49752-6

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Latest article